PacBio Files Q2 2024 10-Q with Revenue Details
Ticker: PACB · Form: 10-Q · Filed: 2024-08-09T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, revenue
Related Tickers: PACB
TL;DR
PACB Q2 10-Q filed. Revenue details out for Q2 and YTD. Check financials.
AI Summary
Pacific Biosciences of California, Inc. (PACB) filed its 10-Q for the period ending June 30, 2024. The company reported revenue for the second quarter of 2024 and year-to-date, with specific figures for product and service revenue. The filing also includes details on common stock and additional paid-in capital as of March 31, 2024.
Why It Matters
This filing provides investors with the latest financial performance data for Pacific Biosciences, crucial for understanding the company's revenue generation and financial health in the second quarter of 2024.
Risk Assessment
Risk Level: medium — 10-Q filings are standard disclosures, but the financial performance and market conditions detailed within can present medium-level investment risks.
Key Numbers
- 2024-06-30 — Period End Date (Quarterly financial reporting period)
- 2024-01-01 — Year-to-Date Start Date (Reporting period for year-to-date financials)
- 2023-12-31 — Previous Fiscal Year End (Reference for comparative financial periods)
- 2024-03-31 — Common Stock Date (Date for common stock information)
Key Players & Entities
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (company) — Filer
- 20240630 (date) — Period of Report
- 20240809 (date) — Filed as of Date
- 1305 O'BRIEN DRIVE (address) — Business Address
- MENLO PARK (city) — Business Address City
- CA (state) — Business Address State
- 94025 (zip_code) — Business Address Zip
- 650-521-8000 (phone_number) — Business Phone
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20240630, indicating the filing covers the period ending June 30, 2024.
What is the company's primary business classification?
The company is classified under Standard Industrial Classification code 3826, which is for Laboratory Analytical Instruments.
Where is Pacific Biosciences of California, Inc. headquartered?
The company's business address is 1305 O'BRIEN DRIVE, MENLO PARK, CA 94025.
What is the SEC file number for this company?
The SEC File Number is 001-34899.
When was the company incorporated?
The company was incorporated in Delaware (DE).
From the Filing
0001299130-24-000169.txt : 20240809 0001299130-24-000169.hdr.sgml : 20240809 20240808204625 ACCESSION NUMBER: 0001299130-24-000169 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 77 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240809 DATE AS OF CHANGE: 20240808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CENTRAL INDEX KEY: 0001299130 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 161590339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-34899 FILM NUMBER: 241190126 BUSINESS ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-521-8000 MAIL ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA INC DATE OF NAME CHANGE: 20050829 FORMER COMPANY: FORMER CONFORMED NAME: NANOFLUIDICS INC DATE OF NAME CHANGE: 20040729 10-Q 1 pacb-20240630.htm 10-Q pacb-20240630 0001299130 12-31 2024 Q2 false P20D 0.0229885 0.0465116 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 0001299130 2024-01-01 2024-06-30 0001299130 2024-07-31 0001299130 2024-06-30 0001299130 2023-12-31 0001299130 us-gaap:ProductMember 2024-04-01 2024-06-30 0001299130 us-gaap:ProductMember 2023-04-01 2023-06-30 0001299130 us-gaap:ProductMember 2024-01-01 2024-06-30 0001299130 us-gaap:ProductMember 2023-01-01 2023-06-30 0001299130 pacb:ServiceAndOtherMember 2024-04-01 2024-06-30 0001299130 pacb:ServiceAndOtherMember 2023-04-01 2023-06-30 0001299130 pacb:ServiceAndOtherMember 2024-01-01 2024-06-30 0001299130 pacb:ServiceAndOtherMember 2023-01-01 2023-06-30 0001299130 2024-04-01 2024-06-30 0001299130 2023-04-01 2023-06-30 0001299130 2023-01-01 2023-06-30 0001299130 us-gaap:CommonStockMember 2024-03-31 0001299130 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001299130 us-gaap:RetainedEarningsMember 2024-03-31 0001299130 2024-03-31 0001299130 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001299130 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001299130 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001299130 us-gaap:CommonStockMember 2024-06-30 0001299130 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001299130 us-gaap:RetainedEarningsMember 2024-06-30 0001299130 us-gaap:CommonStockMember 2023-12-31 0001299130 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001299130 us-gaap:RetainedEarningsMember 2023-12-31 0001299130 us-gaap:RetainedEarningsMember 2024-01-01 2024-06-30 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-06-30 0001299130 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001299130 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-06-30 0001299130 us-gaap:CommonStockMember 2023-03-31 0001299130 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001299130 us-gaap:RetainedEarningsMember 2023-03-31 0001299130 2023-03-31 0001299130 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001299130 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001299130 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001299130 us-gaap:CommonStockMember 2023-06-30 0001299130 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001299130 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001299130 us-gaap:RetainedEarningsMember 2023-06-30 0001299130 2023-06-30 0001299130 us-gaap:CommonStoc